856 related articles for article (PubMed ID: 17288995)
1. The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.
Parmentier R; Anaclet C; Guhennec C; Brousseau E; Bricout D; Giboulot T; Bozyczko-Coyne D; Spiegel K; Ohtsu H; Williams M; Lin JS
Biochem Pharmacol; 2007 Apr; 73(8):1157-71. PubMed ID: 17288995
[TBL] [Abstract][Full Text] [Related]
2. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.
Huang ZL; Mochizuki T; Qu WM; Hong ZY; Watanabe T; Urade Y; Hayaishi O
Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4687-92. PubMed ID: 16537376
[TBL] [Abstract][Full Text] [Related]
3. Histamine H3 receptors and sleep-wake regulation.
Lin JS; Sergeeva OA; Haas HL
J Pharmacol Exp Ther; 2011 Jan; 336(1):17-23. PubMed ID: 20864502
[TBL] [Abstract][Full Text] [Related]
4. Role of histamine H1-receptor on behavioral states and wake maintenance during deficiency of a brain activating system: A study using a knockout mouse model.
Parmentier R; Zhao Y; Perier M; Akaoka H; Lintunen M; Hou Y; Panula P; Watanabe T; Franco P; Lin JS
Neuropharmacology; 2016 Jul; 106():20-34. PubMed ID: 26723880
[TBL] [Abstract][Full Text] [Related]
5. Awakening properties of newly discovered highly selective H₃ receptor antagonists in rats.
Griebel G; Decobert M; Jacquet A; Beeské S
Behav Brain Res; 2012 Jul; 232(2):416-20. PubMed ID: 22561131
[TBL] [Abstract][Full Text] [Related]
6. Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control.
Parmentier R; Ohtsu H; Djebbara-Hannas Z; Valatx JL; Watanabe T; Lin JS
J Neurosci; 2002 Sep; 22(17):7695-711. PubMed ID: 12196593
[TBL] [Abstract][Full Text] [Related]
7. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
[TBL] [Abstract][Full Text] [Related]
8. Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.
Le S; Gruner JA; Mathiasen JR; Marino MJ; Schaffhauser H
J Pharmacol Exp Ther; 2008 Jun; 325(3):902-9. PubMed ID: 18305012
[TBL] [Abstract][Full Text] [Related]
9. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.
Edgar DM; Seidel WF
J Pharmacol Exp Ther; 1997 Nov; 283(2):757-69. PubMed ID: 9353396
[TBL] [Abstract][Full Text] [Related]
10. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study.
Gallopin T; Luppi PH; Rambert FA; Frydman A; Fort P
Sleep; 2004 Feb; 27(1):19-25. PubMed ID: 14998233
[TBL] [Abstract][Full Text] [Related]
11. Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats.
Vanni-Mercier G; Gigout S; Debilly G; Lin JS
Behav Brain Res; 2003 Sep; 144(1-2):227-41. PubMed ID: 12946612
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.
Ligneau X; Lin J; Vanni-Mercier G; Jouvet M; Muir JL; Ganellin CR; Stark H; Elz S; Schunack W; Schwartz J
J Pharmacol Exp Ther; 1998 Nov; 287(2):658-66. PubMed ID: 9808693
[TBL] [Abstract][Full Text] [Related]
13. Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice.
Gondard E; Anaclet C; Akaoka H; Guo RX; Zhang M; Buda C; Franco P; Kotani H; Lin JS
Neuropsychopharmacology; 2013 May; 38(6):1015-31. PubMed ID: 23303066
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat.
Giannoni P; Passani MB; Nosi D; Chazot PL; Shenton FC; Medhurst AD; Munari L; Blandina P
Eur J Neurosci; 2009 Jun; 29(12):2363-74. PubMed ID: 19490084
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activity of the histamine H3 receptor.
Arrang JM; Morisset S; Gbahou F
Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125
[TBL] [Abstract][Full Text] [Related]
16. Altered sleep latency and arousal regulation in mice lacking norepinephrine.
Hunsley MS; Palmiter RD
Pharmacol Biochem Behav; 2004 Aug; 78(4):765-73. PubMed ID: 15301933
[TBL] [Abstract][Full Text] [Related]
17. Effects of modafinil and amphetamine on sleep-wake cycle after sleep deprivation in cats.
Hou YP; Lin JS
Zhongguo Yao Li Xue Bao; 1999 Sep; 20(9):813-8. PubMed ID: 11245089
[TBL] [Abstract][Full Text] [Related]
18. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system.
Witkin JM; Nelson DL
Pharmacol Ther; 2004 Jul; 103(1):1-20. PubMed ID: 15251226
[TBL] [Abstract][Full Text] [Related]
19. Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig.
McLeod RL; Aslanian R; del Prado M; Duffy R; Egan RW; Kreutner W; McQuade R; Hey JA
J Pharmacol Exp Ther; 1998 Oct; 287(1):43-50. PubMed ID: 9765320
[TBL] [Abstract][Full Text] [Related]
20. H3 receptor antagonists/inverse agonists as anti-obesity agents.
Hancock AA
Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
